Who is sponsoring NCT03316092?

NCT03316092 is sponsored by Dr. S.S. Michel Clinic.

What condition does NCT03316092 study?

NCT03316092 studies Hydroxychloroquine Toxicity.

What drugs are being tested in NCT03316092?

Interventions: optical coherence tomography.

What is the status of NCT03316092?

NCT03316092 is currently COMPLETED.

Last reviewed 2017-10-23 · How we verify

Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.

NCT03316092 COMPLETED

Oral Hydoxychloroquine is a very popular medication widely used by patients with rheumatoid arthritis, Systemic Lupus Erythematosus and other diseases. Ocular side effects of this medication are very serious and causes loss of central vision. In most patients these side effects are dose related, cumulative. This means that the risk of side effects would increase in all patients with continued use of the medication. In few people use of the medication would not be recommended if they have some bilateral macular problems. This is because the side effects of this medication does cause serious degredation of the macula in both eyes.

Details

Lead sponsor	Dr. S.S. Michel Clinic
Status	COMPLETED
Enrolment	1000
Start date	Thu Jan 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Hydroxychloroquine Toxicity

Interventions

optical coherence tomography

Countries

Canada